|

Evaluate the Effect of Dietary Supplement Combined Exercise Among Patients With Sarcopenia Comorbid With Lung Disease

RECRUITINGN/ASponsored by Orient Europharma Co., Ltd.
Actively Recruiting
PhaseN/A
SponsorOrient Europharma Co., Ltd.
Started2023-03-01
Est. completion2032-10-31
Eligibility
Healthy vol.Accepted

Summary

This trial is a prospective multi-center study. The purpose of this study is to evaluate the effect of dietary supplement combined with supervised exercised on the physical performance, body composition and lung function among patients with Sarcopenia and severe Sarcopenia in chronic lung disease. After participants enroll in this study, 12-week clinical trial will be conducted to analyze the improvement regarding Sarcopenia and different severity of Sarcopenia before and after the intervention of exercise and nutritional products, which can further provide reference for clinical intervention and rehabilitation.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Outpatients with COPD (chronic obstructive pulmonary disease) or ILD (interstitial lung disease) from Department of Chest medicine in Taichung Veterans General Hospital, judged by the doctor that they do not need hospitalization or emergent treatment.
* Outpatients who meet the diagnostic criteria for Sarcopenia after evaluation by a physician.

Exclusion Criteria:

* Patients who refuse to sign the consent form
* Patients who are under 20 years old
* Patients who are bedridden or unable to walk due to physical disabilities
* Patients with terminal cancer or human-acquired immunodeficiency syndrome
* Patients with edema (grading pitting edema +2)

Conditions3

COPDILDSarcopenia

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.